Rapid development and testing of COVID-19 vaccines from India have reduced the stress on healthcare companies to innovate in therapeutics that treat the novel infection. However, bottom lines in the healthcare industry are gradually reviving with growth in consumer spend. Companies in the radiation dermatitis market are becoming aware about special policies reserved for healthcare as an essential industry amid the ongoing coronavirus era.
Due to a decline in consumer spending, stakeholders in the value chain are being affected due to delayed shipment of raw materials and disruptions in supply chains. Hence, companies in the radiation dermatitis market are adopting contingency plans to stay flexible in production and distribution activities. They are maintaining high inventory levels to avoid supply shocks for essential medications required for radiation dermatitis.
The radiation dermatitis market is expected to reach a valuation of ~US$ 700 Mn by the end of 2030. Manufacturers are boosting their output capacities in wound dressings that are highly elastic and flexible in nature. However, it has been found that these dressings in some cases may damage fragile skin and may not prevent maceration. This has created a need for new biocompatible and biodegradable nanomaterials that help in regulating all phases of wound healing.
Companies in the radiation dermatitis market are increasing their R&D capabilities to develop dressings that incorporate antibacterial and self-healing properties.
Adverse effects of any radiation therapy, such as in the case of breast cancer, may lead to issues such as skin irritation, tenderness in treated area, and changes in skin color. In order to minimize these adverse effects, manufacturers in the radiation dermatitis market are innovating in corticosteroid creams and ointments. Topical sucralfate or hyaluronic acid hold promising potentials in ameliorating the symptoms of patients suffering from radiation dermatitis.
Herbal ingredients such as extracts from the calendula plant are gaining prominence in corticosteroid creams and ointments for topical applications. Patients are preferring non-steroidal ingredients in creams. This explains why the radiation dermatitis market is projected to expand at a modest CAGR of ~5% during the assessment period.
Traditional Chinese medicine (TCM), Jiawei Simiao Yongan Gao, holds promising potentials in minimizing the impact of radio-dermatitis in patients with neck and head cancer. Companies in the radiation dermatitis market are capitalizing on this opportunity to innovate in pastes that improve the symptoms of skin reaction caused due to radiotherapy. They are improving their production capabilities in clear and light drugs that can enter the lung meridian directly.
Honeysuckle is emerging as one of the key ingredients in TCM for the treatment of carbuncles. Manufacturers in the radiation dermatitis market are experimenting with medicines containing angelica sinensis, which appears to nourish and activate the blood and relieve pain by promoting coronary circulation.
Innovations in wound dressings are creating value grab opportunities for companies in the radiation dermatitis market. Stratpharma - a pharmaceutical company in Basel, Switzerland, has introduced its StrataXRT® innovative and film-forming wound dressing gel that easily spreads with only a small amount applied on the affected area of the skin. Companies in the radiation dermatitis market are taking cues from such companies to develop film-forming gels that provide symptomatic relief from acute inflammatory response, discomfort, and itching.
Film-forming gels are a game changer in the class of wound dressings that reduce redness and swelling post exposure toward radiotherapy. Such gels are being used to protect the compromised skin from microbial invasion and prevent bacterial growth. Thus, film-forming wound dressing gels are creating an optimum environment for reducing downtime and enable faster wound healing.
Analysts’ Viewpoint
Companies in the radiation dermatitis market are focusing on continuous R&D innovations to grab the attention of consumers and offer alternate treatment options during the ongoing coronavirus pandemic. Film-forming wound dressing gels are bringing a significant change in the market landscape, since they reduce downtime and enable fast re-epithelialization. However, manufacturers are learning about side effects such as infection and skin atrophy after the application of topical steroids. Hence, companies should adopt traditional Chinese medicine ingredients such as raw astragalus and herbal extracts of the calendula plant to minimize adverse events after the application of creams and ointments. New biocompatible and biodegradable materials are being used to innovate in advanced wound dressings.
The global radiation dermatitis market was worth US$ 400 Mn and is projected to reach a value of US$ 700 Mn by the end of 2030
Radiation dermatitis market is anticipated to grow at a CAGR of 5% during the forecast period
Asia Pacific accounted for a major share of the global radiation dermatitis market
Radiation dermatitis market is driven by rise in prevalence of cancer and increase in adoption of radiation therapy for cancer treatment are projected to drive the global market during the forecast period
Key players in the global radiation dermatitis market include 3M Company, Mölnlycke Health Care AB, Smith & Nephew plc, Integra Lifesciences Holdings Corporation, Intermed S.A., ConvaTec Group plc, and BMG PHARMA S.p.A.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Radiation Dermatitis Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Radiation Dermatitis Market Analysis and Forecast, 2018–2030
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Industry Events
5.3. Overview & Prevalence of Disease
5.4. COVID-19 Pandemic Impact on Industry
6. Global Radiation Dermatitis Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value & Volume Forecast, by Product, 2018–2030
6.3.1. Oral Medication
6.3.1.1. Corticosteroids
6.3.1.2. Oral Analgesics & Antibiotics
6.3.2. Topical
6.3.2.1. Corticosteroids
6.3.2.2. Hydrophilic Creams
6.3.2.3. Topical Antibiotics
6.3.3. Dressings
6.3.3.1. Hydrogel
6.3.3.2. Hydrocolloid
6.3.3.3. No Sting Barrier film
6.3.3.4. Honey Impregnated Gauze
6.3.3.5. Silicone Coated Dressing
6.3.3.6. Others
6.4. Market Attractiveness Analysis, by Product
7. Global Radiation Dermatitis Market Analysis and Forecast, by Distribution Channel
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value & Volume Forecast, by Distribution Channel, 2018–2030
7.3.1. Hospital Pharmacies
7.3.2. Retail Pharmacies
7.3.3. Online Pharmacies
7.4. Market Attractiveness Analysis, by Distribution Channel
8. Global Radiation Dermatitis Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value & Volume Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Country/Region
9. North America Radiation Dermatitis Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value & Volume Forecast, by Product, 2018–2030
9.2.1. Oral Medication
9.2.1.1. Corticosteroids
9.2.1.2. Oral Analgesics & Antibiotics
9.2.2. Topical
9.2.2.1. Corticosteroids
9.2.2.2. Hydrophilic Creams
9.2.2.3. Topical Antibiotics
9.2.3. Dressings
9.2.3.1. Hydrogel
9.2.3.2. Hydrocolloid
9.2.3.3. No Sting Barrier film
9.2.3.4. Honey Impregnated Gauze
9.2.3.5. Silicone Coated Dressing
9.2.3.6. Others
9.3. Market Value & Volume Forecast, by Distribution Channel, 2018–2030
9.3.1. Hospital Pharmacies
9.3.2. Retail Pharmacies
9.3.3. Online Pharmacies
9.4. Market Value & Volume Forecast, by Country, 2018–2030
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By Distribution Channel
9.5.3. By Country
10. Europe Radiation Dermatitis Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value & Volume Forecast, by Product, 2018–2030
10.2.1. Oral Medication
10.2.1.1. Corticosteroids
10.2.1.2. Oral Analgesics & Antibiotics
10.2.2. Topical
10.2.2.1. Corticosteroids
10.2.2.2. Hydrophilic Creams
10.2.2.3. Topical Antibiotics
10.2.3. Dressings
10.2.3.1. Hydrogel
10.2.3.2. Hydrocolloid
10.2.3.3. No Sting Barrier film
10.2.3.4. Honey Impregnated Gauze
10.2.3.5. Silicone Coated Dressing
10.2.3.6. Others
10.3. Market Value & Volume Forecast, by Distribution Channel, 2018–2030
10.3.1. Hospital Pharmacies
10.3.2. Retail Pharmacies
10.3.3. Online Pharmacies
10.4. Market Value & Volume Forecast, by Country/Sub-Region, 2018–2030
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By Distribution Channel
10.5.3. By Country/Sub-Region
11. Asia Pacific Radiation Dermatitis Market Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2.Market Value & Volume Forecast, by Product, 2018–2030
11.2.1. Oral Medication
11.2.1.1. Corticosteroids
11.2.1.2. Oral Analgesics & Antibiotics
11.2.2. Topical
11.2.2.1. Corticosteroids
11.2.2.2. Hydrophilic Creams
11.2.2.3. Topical Antibiotics
11.2.3. Dressings
11.2.3.1. Hydrogel
11.2.3.2. Hydrocolloid
11.2.3.3. No Sting Barrier film
11.2.3.4. Honey Impregnated Gauze
11.2.3.5. Silicone Coated Dressing
11.2.3.6. Others
11.3.Market Value & Volume Forecast, by Distribution Channel, 2018–2030
11.3.1. Hospital Pharmacies
11.3.2. Retail Pharmacies
11.3.3. Online Pharmacies
11.4.Market Value & Volume Forecast, by Country/Sub-Region, 2018–2030
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5.Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By Distribution Channel
11.5.3. By Country/Sub-Region
12. Latin America Radiation Dermatitis Market Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2.Market Value & Volume Forecast, by Product, 2018–2030
12.2.1. Oral Medication
12.2.1.1. Corticosteroids
12.2.1.2. Oral Analgesics & Antibiotics
12.2.2. Topical
12.2.2.1. Corticosteroids
12.2.2.2. Hydrophilic Creams
12.2.2.3. Topical Antibiotics
12.2.3. Dressings
12.2.3.1. Hydrogel
12.2.3.2. Hydrocolloid
12.2.3.3. No Sting Barrier film
12.2.3.4. Honey Impregnated Gauze
12.2.3.5. Silicone Coated Dressing
12.2.3.6. Others
12.3.Market Value & Volume Forecast, by Distribution Channel, 2018–2030
12.3.1. Hospital Pharmacies
12.3.2. Retail Pharmacies
12.3.3. Online Pharmacies
12.4.Market Value & Volume Forecast, by Country/Sub-Region, 2018–2030
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5.Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By Distribution Channel
12.5.3. By Country/Sub-Region
13. Middle East & Africa Radiation Dermatitis Market Analysis and Forecast
13.1.Introduction
13.1.1. Key Findings
13.2.Market Value & Volume Forecast, by Product, 2018–2030
13.2.1. Oral Medication
13.2.1.1. Corticosteroids
13.2.1.2. Oral Analgesics & Antibiotics
13.2.2. Topical
13.2.2.1. Corticosteroids
13.2.2.2. Hydrophilic Creams
13.2.2.3. Topical Antibiotics
13.2.3. Dressings
13.2.3.1. Hydrogel
13.2.3.2. Hydrocolloid
13.2.3.3. No Sting Barrier film
13.2.3.4. Honey Impregnated Gauze
13.2.3.5. Silicone Coated Dressing
13.2.3.6. Others
13.3.Market Value & Volume Forecast, by Distribution Channel, 2018–2030
13.3.1. Hospital Pharmacies
13.3.2. Retail Pharmacies
13.3.3. Online Pharmacies
13.4.Market Value & Volume Forecast, by Country/Sub-Region, 2018–2030
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5.Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By Distribution Channel
13.5.3. By Country/Sub-Region
14. Competition Landscape
14.1. Market Player – Competition Matrix (by tier and size of companies)
14.2. Company Profiles
14.2.1. 3M Company
14.2.1.1. by tier
14.2.1.2. size of companies
14.2.2. Mölnlycke Health Care AB
14.2.2.1. by tier
14.2.2.2. size of companies
14.2.3. Smith & Nephew plc
14.2.3.1. by tier
14.2.3.2. size of companies
14.2.4. Integra Lifesciences Holdings Corporation
14.2.4.1. by tier
14.2.4.2. size of companies
14.2.5. Intermed S.A.
14.2.5.1. by tier
14.2.5.2. size of companies
14.2.6. ConvaTec Group plc
14.2.6.1. by tier
14.2.6.2. size of companies
14.2.7. BMG PHARMA S.p.A.
14.2.7.1. by tier
14.2.7.2. size of companies
List of Tables
Table 01: Global Radiation Dermatitis Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 02: Global Radiation Dermatitis Market Value (US$ Mn) Forecast, by Oral Medication, 2018–2030
Table 03: Global Radiation Dermatitis Market Value (US$ Mn) Forecast, by Topical, 2018–2030
Table 04: Global Radiation Dermatitis Market Value (US$ Mn) Forecast, by Dressings, 2018–2030
Table 05: Global Radiation Dermatitis Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 06: Global Radiation Dermatitis Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 07: North America Radiation Dermatitis Market Value (US$ Mn) Forecast, by Country, 2018–2030
Table 08: North America Radiation Dermatitis Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 09: North America Radiation Dermatitis Market Value (US$ Mn) Forecast, by Oral Medication, 2018–2030
Table 10: North America Radiation Dermatitis Market Value (US$ Mn) Forecast, by Topical, 2018–2030
Table 11: North America Radiation Dermatitis Market Value (US$ Mn) Forecast, by Dressings, 2018–2030
Table 12: North America Radiation Dermatitis Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 13: Europe Radiation Dermatitis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 14: Europe Radiation Dermatitis Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 15: Europe Radiation Dermatitis Market Value (US$ Mn) Forecast, by Oral Medication, 2018–2030
Table 16: Europe Radiation Dermatitis Market Value (US$ Mn) Forecast, by Topical, 2018–2030
Table 17: Europe Radiation Dermatitis Market Value (US$ Mn) Forecast, by Dressings, 2018–2030
Table 18: Europe Radiation Dermatitis Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 19: Asia Pacific Radiation Dermatitis Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2018–2030
Table 20: Asia Pacific Radiation Dermatitis Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 21: Asia Pacific Radiation Dermatitis Market Value (US$ Mn) Forecast, by Oral Medication, 2018–2030
Table 22: Asia Pacific Radiation Dermatitis Market Value (US$ Mn) Forecast, by Topical, 2018–2030
Table 23: Asia Pacific Radiation Dermatitis Market Value (US$ Mn) Forecast, by Dressings, 2018–2030
Table 24: Asia Pacific Radiation Dermatitis Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 25: Latin America Radiation Dermatitis Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2018–2030
Table 26: Latin America Radiation Dermatitis Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 27: Latin America Radiation Dermatitis Market Value (US$ Mn) Forecast, by Oral Medication, 2018–2030
Table 28: Latin America Radiation Dermatitis Market Value (US$ Mn) Forecast, by Topical, 2018–2030
Table 29: Latin America Radiation Dermatitis Market Value (US$ Mn) Forecast, by Dressings, 2018–2030
Table 30: Latin America Radiation Dermatitis Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 31: Middle East & Africa Radiation Dermatitis Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2018–2030
Table 32: Middle East & Africa Radiation Dermatitis Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 33: Middle East & Africa Radiation Dermatitis Market Value (US$ Mn) Forecast, by Oral Medication, 2018–2030
Table 34: Middle East & Africa Radiation Dermatitis Market Value (US$ Mn) Forecast, by Topical, 2018–2030
Table 35: Middle East & Africa Radiation Dermatitis Market Value (US$ Mn) Forecast, by Dressings, 2018–2030
Table 36: Middle East & Africa Radiation Dermatitis Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
List of Figure
Figure 01: Global Radiation Dermatitis Market Value (US$ Mn) Forecast, 2018–2030
Figure 02: Global Radiation Dermatitis Market Value Share, by Product, 2019
Figure 03: Global Radiation Dermatitis Market Value Share, by Distribution Channel, 2019
Figure 04: Global Radiation Dermatitis Market Value Share, by Region, 2019
Figure 05: Global Radiation Dermatitis Market Value Share Analysis, by Product, 2019 and 2030
Figure 06: Global Radiation Dermatitis Market Attractiveness Analysis, by Product, 2020–2030
Figure 07: Global Radiation Dermatitis Market Value (US$ Mn), by Oral Medication, 2018–2030
Figure 08: Global Radiation Dermatitis Market Value (US$ Mn), by Topical, 2018–2030
Figure 09: Global Radiation Dermatitis Market Value (US$ Mn), by Dressings, 2018–2030
Figure 10: Global Radiation Dermatitis Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 11: Global Radiation Dermatitis Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 12: Global Radiation Dermatitis Market Value (US$ Mn), by Hospital Pharmacies, 2018–2030
Figure 13: Global Radiation Dermatitis Market Value (US$ Mn), by Retail Pharmacies, 2018–2030
Figure 14: Global Radiation Dermatitis Market Value (US$ Mn), by Online Pharmacies, 2018–2030
Figure 15: Global Radiation Dermatitis Market Attractiveness Analysis, by Region, 2019 and 2030
Figure 16: Global Radiation Dermatitis Market Value Share Analysis, by Region, 2020–2030
Figure 17: North America Radiation Dermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 18: North America Radiation Dermatitis Market Value Share Analysis, by Country, 2019 and 2030
Figure 19: North America Radiation Dermatitis Market Attractiveness Analysis, by Country, 2019–2030
Figure 20: North America Radiation Dermatitis Market Value Share Analysis, by Product, 2019 and 2030
Figure 21: North America Radiation Dermatitis Market Attractiveness Analysis, by Product, 2020–2030
Figure 22: North America Radiation Dermatitis Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 23: North America Radiation Dermatitis Market Attractiveness Analysis, by Distribution Channel, 2019–2030
Figure 24: Europe Radiation Dermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 25: Europe Radiation Dermatitis Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure 26: Europe Radiation Dermatitis Market Attractiveness Analysis, by Country/Sub-region, 2019–2030
Figure 27: Europe Radiation Dermatitis Market Value Share Analysis, by Product, 2019 and 2030
Figure 28: Europe Radiation Dermatitis Market Attractiveness Analysis, by Product, 2020–2030
Figure 29: Europe Radiation Dermatitis Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 30: Europe Radiation Dermatitis Market Attractiveness Analysis, by Distribution Channel, 2019–2030
Figure 31: Asia Pacific Radiation Dermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 32: Asia Pacific Radiation Dermatitis Market Value Share Analysis, by Country/Sub-Region, 2019 and 2030
Figure 33: Asia Pacific Radiation Dermatitis Market Attractiveness Analysis, by Country/Sub-Region, 2019–2030
Figure 34: Asia Pacific Radiation Dermatitis Market Value Share Analysis, by Product, 2019 and 2030
Figure 35: Asia Pacific Radiation Dermatitis Market Attractiveness Analysis, by Product, 2020–2030
Figure 36: Asia Pacific Radiation Dermatitis Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 37: Asia Pacific Radiation Dermatitis Market Attractiveness Analysis, by Distribution Channel, 2019–2030
Figure 38: Latin America Radiation Dermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 39: Latin America Radiation Dermatitis Market Value Share Analysis, by Country/Sub-Region, 2019 and 2030
Figure 40: Latin America Radiation Dermatitis Market Attractiveness Analysis, by Country/Sub-Region, 2019–2030
Figure 41: Latin America Radiation Dermatitis Market Value Share Analysis, by Product, 2019 and 2030
Figure 42: Latin America Radiation Dermatitis Market Attractiveness Analysis, by Product, 2020–2030
Figure 43: Latin America Radiation Dermatitis Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 44: Latin America Radiation Dermatitis Market Attractiveness Analysis, by Distribution Channel, 2019–2030
Figure 45: Middle East & Africa Radiation Dermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 46: Middle East & Africa Radiation Dermatitis Market Value Share Analysis, by Country/Sub-Region, 2019 and 2030
Figure 47: Middle East & Africa Radiation Dermatitis Market Attractiveness Analysis, by Country/Sub-Region, 2019–2030
Figure 48: Middle East & Africa Radiation Dermatitis Market Value Share Analysis, by Product, 2019 and 2030
Figure 49: Middle East & Africa Radiation Dermatitis Market Attractiveness Analysis, by Product, 2020–2030
Figure 50: Middle East & Africa Radiation Dermatitis Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 51: Middle East & Africa Radiation Dermatitis Market Attractiveness Analysis, by Distribution Channel, 2019–2030
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Radiation Dermatitis Market Forecast, 2020-2030
